nach oben

Erschienen in:

02.06.2022 | Consensus papers and Guidelines

Patient-reported outcome and cognitive measures to be used in vascular and brain tumor surgery: proposal for a minimum set

verfasst von: Silvia Schiavolin, Arianna Mariniello, Morgan Broggi, Giorgia Abete-Fornara, Alessandra Bollani, Giulio Palmas G, Gabriella Bottini, Matteo Querzola, Pina Scarpa, Alessandra Casarotti, Sara De Michele, Valeria Isella, Ilaria Mauri, Alessandra Maietti, Valentina Miramonti, Maria Immacolata Orru, Marta Pertichetti, Elisa Pini, Rossana Regazzoni, Sara Subacchi, Paolo Ferroli, Matilde Leonardi

Erschienen in: Neurological Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The standardization of outcome measures is needed for comparing studies and using common measures in clinical practice. We aimed to identify cognitive and patient-reported outcomes and timing of assessment for glioma, meningioma, and vascular surgery.

Method

A consensus study was conducted. Participants selected cognitive and patient-reported measures among a list of instruments identified through a literature search.

Results

Seventeen cognitive tests for the glioma and meningioma’s evaluation, 8 for the vascular diseases, and one questionnaire on quality of life and one on emotional distress were identified. The timing of outcome assessment selected was before surgery, at discharge, and after 3 and 12 months for glioma; before surgery and after 3 months for meningioma; before surgery, at discharge, and after 6 months for vascular diseases.

Conclusion

The identification of common outcome measures is the first step toward a shared data collection improving the quality and comparability of future studies.

Nur mit Berechtigung zugänglich

Kirkham JJ, Dwan KM, Altman DG et al (2010) The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340:365. https://doi.org/10.1136/bmj.c365CrossRef

Macefield RC, Jacobs M, Korfage IJ et al (2014) Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs). Trials 15:49. https://doi.org/10.1186/1745-6215-15-49CrossRefPubMedPubMedCentral

Grinnon ST, Miller K, Marler JR et al (2012) National Institute of Neurological Disorders and Stroke Common Data Element Project-approach and methods. Clin Trials 9(3):322–329. https://doi.org/10.1177/1740774512438980CrossRefPubMedPubMedCentral

Williamson PR, Altman DG, Blazeby JM et al (2012) Developing core outcome sets for clinical trials: issues to consider. Trials 13:132. https://doi.org/10.1186/1745-6215-13-132CrossRefPubMedPubMedCentral

Papagno C, Casarotti A, Comi A et al (2012) Measuring clinical outcomes in neuro-oncology. A battery to evaluate low-grade gliomas (LGG). J Neurooncol 108(2):269–275. https://doi.org/10.1007/s11060-012-0824-5CrossRefPubMed

Rofes A, Mandonnet E, Godden J et al (2017) Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol. Acta Neurochir (Wien) 159(7):1167–1178. https://doi.org/10.1007/s00701-017-3192-2CrossRef

Yoshii Y, Tominaga D, Sugimoto K et al (2008) Cognitive function of patients with brain tumor in pre- and postoperative stage. Surg Neurol 69(1):51–61. https://doi.org/10.1016/j.surneu.2007.07.064CrossRefPubMed

Dijkstra M, Van Nieuwenhuizen D, Stalpers LJA et al (2009) Late neurocognitive sequelae in patients with WHO grade I meningioma. J Neurol Neurosurg Psychiatry 80(8):910–915. https://doi.org/10.1136/jnnp.2007.138925CrossRefPubMed

Waagemans ML, Van Nieuwenhuizen D, Dijkstra M et al (2011) Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas. Neurosurgery 69(1):72–78. https://doi.org/10.1227/NEU.0b013e318212badbCrossRefPubMed

10.

Stienen MN, Visser-Meily JM, Schweizer TA et al (2019) Prioritization and timing of outcomes and endpoints after aneurysmal subarachnoid hemorrhage in clinical trials and observational studies: proposal of a multidisciplinary research group. Neurocrit Care 30:102–113. https://doi.org/10.1007/s12028-019-00737-0CrossRefPubMed

11.

Kazim SF, Ogulnick JV, Robinson MB et al (2021) Cognitive impairment after intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg 148:141–162. https://doi.org/10.1016/j.wneu.2021.01.026CrossRefPubMed

12.

Armstrong TS, Dirven L, Arons D et al (2020) Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol 21(2):e97–e103. https://doi.org/10.1016/S1470-2045(19)30796-XCrossRefPubMed

13.

De Witt Hamer PC, Klein M, Hervey-Jumper SL et al (2021) Functional outcomes and health-related quality of life following glioma surgery. Neurosurgery 88(4):720–732. https://doi.org/10.1093/neuros/nyaa365CrossRefPubMedPubMedCentral

14.

Corniola MV, Meling TR (2021) Functional outcome and quality of life after meningioma surgery: a systematic review. Acta Neurol Scand 143(5):467–474. https://doi.org/10.1111/ane.13395CrossRefPubMed

15.

Van Coevorden-van Loon EMP, Heijenbrok-Kal MH, Van Loon WS et al (2015) Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med 47(6):481–488. https://doi.org/10.2340/16501977-1975CrossRef

16.

Meskal I, Gehring K, Rutten GJM, Sitskoorn MM (2016) Cognitive functioning in meningioma patients: a systematic review. J Neurooncol 128(2):195–205. https://doi.org/10.1007/s11060-016-2115-zCrossRefPubMedPubMedCentral

17.

Andersen CR, Fitzgerald E, Delaney A, Finfer S (2019) A systematic review of outcome measures employed in aneurysmal subarachnoid hemorrhage (aSAH) clinical research. Neurocrit Care 30(3):534–541. https://doi.org/10.1007/s12028-018-0566-0CrossRefPubMed

18.

Sumsion T (1998) The Delphi technique: an adaptive research tool. Br J Occup Ther 64(4):153–156. https://doi.org/10.1177/030802269806100403CrossRef

19.

Butts AM, Weigand S, Brown PD et al (2017) Neurocognition in individuals with incidentally-identified meningioma. J Neurooncol 134:125–132. https://doi.org/10.1007/s11060-017-2495-8CrossRefPubMedPubMedCentral

20.

Zamanipoor Najafabadi AH, Peeters MCM, Dirven L et al (2017) Impaired health-related quality of life in meningioma patients - a systematic review. Neuro Oncol 19(7):897–907. https://doi.org/10.1093/neuonc/now250CrossRefPubMed

21.

Luckett T, King MT, Butow PN et al (2011) Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 22(10):2179–2190. https://doi.org/10.1093/annonc/mdq721CrossRefPubMed

22.

Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. https://doi.org/10.1093/jnci/85.5.365CrossRefPubMed

23.

Costantini M, Musso M, Viterbori P et al (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer 7(3):121–127. https://doi.org/10.1007/s005200050241CrossRefPubMed

24.

Langsdale T (1997) Eq-5D: a generic tool for outcomes measurement. PharmacoEcon Outcome News 109(1):3–4. https://doi.org/10.1007/bf03271524CrossRef

25.

Waggoner J, Carline JD, Durning SJ (2016) Is there a consensus on consensus methodology? Descriptions and recommendations for future consensus research. Acad Med 91(5):663–668. https://doi.org/10.1097/ACM.0000000000001092CrossRefPubMed

26.

Schiavolin S, Raggi A, Scaratti C et al (2018) Patients’ reported outcome measures and clinical scales in brain tumor surgery: results from a prospective cohort study. Acta Neurochir (Wien) 160(5):1053–1061. https://doi.org/10.1007/s00701-018-3505-0CrossRef

27.

Sagberg LM, Drewes C, Jakola AS, Solheim O (2017) Accuracy of operating neurosurgeons’ prediction of functional levels after intracranial tumor surgery. J Neurosurg 126(4):1173–1180. https://doi.org/10.3171/2016.3.JNS152927CrossRefPubMed

28.

Reponen E, Tuominen H, Hernesniemi J, Korja M (2015) Patient-reported outcomes in elective cranial neurosurgery. World Neurosurg 84(6):1845–1851. https://doi.org/10.1016/j.wneu.2015.08.007CrossRefPubMed

29.

Drewes C, Sagberg ML, Jakola AS et al (2015) Morbidity after intracranial tumor surgery: sensitivity and specificity of retrospective review of medical records compared with patient-reported outcomes at 30 days. J Neurosurg 123:972–977. https://doi.org/10.3171/2015.3.JNS142959CrossRefPubMed

Titel: Patient-reported outcome and cognitive measures to be used in vascular and brain tumor surgery: proposal for a minimum set
verfasst von: Silvia Schiavolin
Arianna Mariniello
Morgan Broggi
Giorgia Abete-Fornara
Alessandra Bollani
Giulio Palmas G
Gabriella Bottini
Matteo Querzola
Pina Scarpa
Alessandra Casarotti
Sara De Michele
Valeria Isella
Ilaria Mauri
Alessandra Maietti
Valentina Miramonti
Maria Immacolata Orru
Marta Pertichetti
Elisa Pini
Rossana Regazzoni
Sara Subacchi
Paolo Ferroli
Matilde Leonardi
Publikationsdatum: 02.06.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 8/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06162-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

Coexistent cerebral small vessel disease and multiple infarctions predict recurrent stroke

Is hypnotic assessment relevant to neurology?

Cognitive functioning in essential tremor without dementia: a clinical and imaging study

Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data

Comparison of characteristics, management and outcomes in hospital-onset and community-onset stroke: a multi-centre registry-based cohort study of acute stroke